Sean Lee

Stock Analyst at HC Wainwright & Co.

(4.00)
# 576
Out of 5,182 analysts
97
Total ratings
33.68%
Success rate
20.55%
Average return
Main Sectors:

Stocks Rated by Sean Lee

Dogwood Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $12
Current: $1.41
Upside: +751.00%
Akari Therapeutics,
Apr 1, 2026
Maintains: Buy
Price Target: $1.6$27
Current: $5.60
Upside: +382.14%
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11$16
Current: $8.02
Upside: +99.50%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $11.75
Upside: +53.26%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $50$25
Current: $6.03
Upside: +314.59%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11$27
Current: $16.07
Upside: +68.01%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $10.15
Upside: +136.45%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1$0.75
Current: $0.62
Upside: +21.46%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4$19
Current: $7.43
Upside: +148.99%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5$5
Current: $0.81
Upside: +514.06%
Maintains: Buy
Price Target: $10$14
Current: $5.42
Upside: +158.30%
Reiterates: Buy
Price Target: $40
Current: $54.20
Upside: -26.20%